BACKGROUND: Acinetobacter baumannii is an opportunistic pathogen posing an increased risk to hospitalized persons, causing nosocomial pneumonias, urinary tract infections and postoperative infections. METHODS: Between 1 December 2011 and 30 September 2012, strains of Acinetobacter spp. were isolated from clinical samples obtained from hospitalized patients. Susceptibility to antibiotics was determined by the standard microdilution method and phenotypic testing was used to detect the presence of serine carbapenemases and metallo-beta-lactamases. The polymerase chain reaction was used to detect the genes encoding carbapenemases. Pulsed field gel electrophoresis was used to investigate the genetic relationship among the carbapenem resistant isolates of Acinetobacter baumannii. RESULTS: In three strains of Acinetobacter baumannii enzyme OXA-23 was detected. This positive result was confirmed by restriction analysis and sequencing. The study reported an OXA-23-producing strains of Acinetobacter baumannii in the Czech Republic. All three strains isolated from Military Hospital patients had a completely identical restriction profile, indicating clonal spread of a strain carrying serine carbapenemase OXA-23 in this health care facility. Moreover this was the first time the strain was detected in the country in patients who had not stayed abroad.

Department of Microbiology Faculty of Medicine and Dentistry Palacky University Olomouc Hněvotínská 5 Olomouc 77900 Czech Republic

Zobrazit více v PubMed

Acosta J, Merino M, Viedma E, et al. Multidrug-resistant Acinetobacter baumannii harboring OXA-24 carbapenemase, Spain. Emerg Infect Dis. 2011;17:1064–1067. doi: 10.3201/eid1706.091866. PubMed DOI PMC

Ambler RP. The structure of β-lactamases. Philo Tran R Soc Lon B Biol Sci. 1980;289:321–331. doi: 10.1098/rstb.1980.0049. PubMed DOI

Aubron C, Poirel L, Ash RJ, et al. Carbapenemase-producing Enterobacteriaceae, U.S. rivers. Emerg Infect Dis. 2005;11:260–264. doi: 10.3201/eid1102.030684. PubMed DOI PMC

Bogaerts P, Naas T, Wybo I, et al. Outbreak of infection by carbapenem-resistant Acinetobacter baumannii producing the carbapenemase OXA-58 in Belgium. J Clin Microbiol. 2006;44:4189–4192. doi: 10.1128/JCM.00796-06. PubMed DOI PMC

Bradford PA, Bratu S, Urban C, et al. Emergence of carbapenem-resistant Klebsiella species possessing the class A carbapenemhydrolyzing KPC-2 and inhibitor-resistant TEM-30 beta-lactamases in New York City. Clin Infect Dis. 2004;39:55–60. doi: 10.1086/421495. PubMed DOI

Bush K, Jacoby GA. Updated functional classification of β-lactamases. Antimicrob Agent Chemother. 2010;54:969–976. doi: 10.1128/AAC.01009-09. PubMed DOI PMC

Carvalho KR, D’Alincourt Carvalho-Assef AP, Galvão dos Santos L, et al. Occurrence of blaOXA-23 gene in imipenem-susceptible Acinetobacter baumannii. Mem Inst Oswaldo Cruz. 2011;106:505–506. doi: 10.1590/S0074-02762011000400020. PubMed DOI

Coelho J, Woodford N, Livermore DM. Multiresistant acinetobacter in the UK: how big a threat? J Hosp Infect. 2004;58:167–169. doi: 10.1016/j.jhin.2003.12.019. PubMed DOI

Coelho JM, Turton JF, Kaufmann ME, et al. Occurrence of carbapenem-resistant Acinetobacter baumannii clones at multiple hospitals in London and Southeast England. J Clin Microbiol. 2006;44:3623–3627. doi: 10.1128/JCM.00699-06. PubMed DOI PMC

Corvec S, Poirel L, Naas T, et al. Genetics and expression of the carbapenem-hydrolyzing oxacillinase gene blaOXA-23 in Acinetobacter baumannii. Antimicrob Agents Chemother. 2007;51:1530–1533. doi: 10.1128/AAC.01132-06. PubMed DOI PMC

Dalla-Costa LM, Coelho JM, Souza HAPHM, et al. Outbreak of carbapenem-resistant Acinetobacter baumannii producing the OXA-23 enzyme in Curitiba, Brazil. J Clin Microbiol. 2003;41:3403–3406. doi: 10.1128/JCM.41.7.3403-3406.2003. PubMed DOI PMC

Dijkshoorn L, Nemec A, Seifert H. An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii. Natur Rev Microbiol. 2007;5:939–951. doi: 10.1038/nrmicro1789. PubMed DOI

Donald HM, Scaife W, Amyes SG, et al. Sequence analysis of ARI-1, a novel OXA beta-lactamase, responsible for imipenem resistance in Acinetobacter baumannii 6B92. Antimicrob Agents Chemother. 2000;44:196–199. doi: 10.1128/AAC.44.1.196-199.2000. PubMed DOI PMC

Växjö. Sweden: Breakpoint tables for interpretation of MICs and zone diameters; 2012.

Higgins PG, Poirel L, Lehmann M, et al. OXA-143, a novel carbapenem-hydrolyzing class D β-lactamase in Acinetobacter baumannii. Antimicrob Agents Chemother. 2009;53:5035–5038. doi: 10.1128/AAC.00856-09. PubMed DOI PMC

Higgins PG, Dammhayn C, Hackel M, et al. Global spread of carbapenem-resistant Acinetobacter baumannii. J Antimicrob Chemother. 2010;65:233–238. doi: 10.1093/jac/dkp428. PubMed DOI

Hsueh P-R, Teng L-J, Chen C-Y, et al. Pandrug-resistant Acinetobacter baumannii causing nosocomial infections in a university hospital, Taiwan. Emerg Infect Dis. 2002;8:827–832. doi: 10.3201/eid0808.020014. PubMed DOI PMC

Husičková V, Čekanová L, Chromá M, et al. Carriage of ESBL- and AmpC-positive Enterobacteriaceae in the gastrointestinal tract of community subjects and hospitalized patients in the Czech Republic. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2012;156:348–353. PubMed

Jeon BC, Jeong SH, Bae IK, et al. Investigation of a nosocomial outbreak of imipenem-resistant Acinetobacter baumannii producing the OXA-23 beta-lactamase in Korea. J Clin Microbiol. 2005;43:2241–2245. doi: 10.1128/JCM.43.5.2241-2245.2005. PubMed DOI PMC

Kim JW, Heo ST, Jin JS, et al. Characterization of Acinetobacter baumannii carrying blaOXA-23, blaPER-1 and armA in a Korean hospital. Clin Microbiol Infect. 2008;14:716–718. doi: 10.1111/j.1469-0691.2008.02022.x. PubMed DOI

Křížová L, Bonnin RA, Nordmann P, et al. Characterization of a multidrug-resistant Acinetobacter baumannii strain carrying the blaNDM-1 and blaOXA-23 from the Czech republic. J Antimicrob Chemother. 2012;67:1550–1552. doi: 10.1093/jac/dks064. PubMed DOI

Lee K, Chong Y, Shin HB, et al. Modified Hodge and EDTA-disk synergy tests to screen metallo-β-lactamase-producing strains of Pseudomonas and Acinetobacter species. J Clin Microbiol. 2009;47:1631–1639. doi: 10.1128/JCM.00130-09. PubMed DOI

Lolans K, Rice TW, Munoz-Price LS, Quinn JP. Multicity outbreak of carbapenem-resistant Acinetobacter baumannii isolates producing the carbapenemase OXA-40. Antimicrob Agents Chemother. 2006;50:2941–2945. doi: 10.1128/AAC.00116-06. PubMed DOI PMC

Luna CM, Vujacich P, Niederman MS, et al. Impact of BAL data on the therapy and outcome of ventilator-associated pneumonia. Chest. 1997;111:676–685. doi: 10.1378/chest.111.3.676. PubMed DOI

Marais E, de Jong G, Ferraz V, et al. Interhospital transfer of pan-resistant Acinetobacter strains in Johannesburg, South Africa. Am J Infect Control. 2004;32:278–281. doi: 10.1016/j.ajic.2003.11.004. PubMed DOI

Mendes RE, Bell JM, Turnidge JD, et al. Emergence and widespread dissemination of OXA-23, -24/40 and −58 carbapenemases among Acinetobacter spp. in Asia-Pacific nations: report from the SENTRY surveillance program. J Antimicrob Chemother. 2009;63:55–59. doi: 10.1093/jac/dkn434. PubMed DOI

Merkier AK, Catalano M, Ramirez MS, et al. Polyclonal spread of blaOXA-23 and blaOXA-58 in Acinetobacter baumannii isolates from Argentina. J Infect Dev Countr. 2008;2:235–240. PubMed

Micek ST, Lloyd AE, Ritchie DJ, et al. Pseudomonas aeruginosa bloodstream infection: importance of appropriate initial antimicrobial treatment. Antimicrob Agents Chemother. 2005;49:1306–1311. doi: 10.1128/AAC.49.4.1306-1311.2005. PubMed DOI PMC

Mugnier PD, Poirel L, Naas T, et al. Worldwide Dissemination of the blaOXA-23 Carbapenemase Gene of Acinetobacter baumannii. Emerg Infect Dis. 2010;16:35–40. doi: 10.3201/eid1601.090852. PubMed DOI PMC

Nemec A, Křížová L, Maixnerová M, et al. Emergence of carbapenem resistance in Acinetobacter baumannii in the Czech republic is associated with the spread of multidrug-resistant strains of European clone II. J Antimicrob Chemother. 2008;62:484–489. doi: 10.1093/jac/dkn205. PubMed DOI

Pasteran F, Mendez T, Guerriero L, et al. Sensitive screening tests for suspected class A carbapenemase production in species of Enterobacteriaceae. J Clin Microbiol. 2009;47:1631–1639. doi: 10.1128/JCM.00130-09. PubMed DOI PMC

Paton R, Miles RS, Hood J, et al. ARI-1: beta-lactamase-mediated imipenem resistance in Acinetobacter baumannii. Int J Antimicrob Agents. 1993;2:81–88. doi: 10.1016/0924-8579(93)90045-7. PubMed DOI

Peleg AY, Bell JM, Hofmeyr A, et al. Inter-country transfer of Gram-negative organisms carrying the VIM-4 and OXA-58 carbapenem-hydrolysing enzymes. J Antimicrob Chemother. 2006;57:794–795. doi: 10.1093/jac/dkl036. PubMed DOI

Peleg AY, Seifert H, Paterson DL. Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol. 2008;21:538–582. doi: 10.1128/CMR.00058-07. PubMed DOI PMC

Poirel L, Heritier C, Toluen V, et al. Emergence of oxacillinase-mediated resistance to imipenem in Klebsiella pneumoniae. Antimicrob Agents Chemother. 2004;48:15–22. doi: 10.1128/AAC.48.1.15-22.2004. PubMed DOI PMC

Poirel L, Naas T, Nordmann P. Diversity, epidemiology, and genetics of class D beta-lactamases. Antimicrob Agents Chemother. 2010;54:24–38. doi: 10.1128/AAC.01512-08. PubMed DOI PMC

Pournaras S, Poulou A, Tsakris A. Inhibitor-based methods for the detection of KPC carbapenemase-producing Enterobacteriaceae in clinical practice by using boronic acid compounds. J Antimicrob Chemother. 2010;65:1319–1321. doi: 10.1093/jac/dkq124. PubMed DOI

Queenan AM, Torres-Viera C, Gold HS, et al. SME-type carbapenem-hydrolyzing class A β-lactamases from geographically diverse Serratia marcescens strains. Antimicrob Agents Chemother. 2000;44:3035–3039. doi: 10.1128/AAC.44.11.3035-3039.2000. PubMed DOI PMC

Radice M, Power P, Gutkind G, et al. First class A carbapenemase isolated from Enterobacteriaceae in Argentina. Antimicrob Agents Chemother. 2004;48:1068–1069. doi: 10.1128/AAC.48.3.1068-1069.2004. PubMed DOI PMC

Rello J, Torres A, Ricart M, et al. Ventilator-associated pneumonia by Staphylococcus aureus. Comparison of methicillin-resistant and methicillin-sensitive episodes. Am J Respir Crit Care Med. 1994;150:1545–1549. doi: 10.1164/ajrccm.150.6.7952612. PubMed DOI

Scaife W, Young HK, Paton RH, et al. Transferable imipenem-resistance in Acinetobacter species from a clinical source. J Antimicrob Chemother. 1995;36:585–586. doi: 10.1093/jac/36.3.585. PubMed DOI

Stoeva T, Higgins PG, Bojkova K, et al. Clonal spread of carbapenem-resistant OXA-23-positive Acinetobacter baumannii in a Bulgarian university hospital. Clin Microbiol Infect. 2008;14:723–727. doi: 10.1111/j.1469-0691.2008.02018.x. PubMed DOI

Trecarichi EM, Tubarello M, Caira M, et al. Multidrug resistant Pseudomonas aeruginosa bloodstream infection in adult patients with hematologic malignancies. Haematologica. 2011;96:e1–e3. doi: 10.3324/haematol.2010.036640. PubMed DOI PMC

Tsakris A, Ikonomidis A, Poulou A. Clusters of imipenem-resistant Acinetobacter baumannii clones producing different carbapenemases in an intensive care unit. Clin Microbiol Infect. 2008;14:588–594. doi: 10.1111/j.1469-0691.2008.01996.x. PubMed DOI

Uvizl R, Hanulik V, Husickova V, et al. Hospital-acquired pneumonia in ICU patients. Pap Med Fac Univ Palacky Olomouc Czech Repub. 2011;155:373–378. doi: 10.5507/bp.2011.067. PubMed DOI

Van Den Broek PJ, Arends J, Bernards AT, et al. Epidemiology of multiple Acinetobacter outbreaks in The Netherlands during the period 1999–2001. Clin Microbiol Infect. 2006;12:837–843. doi: 10.1111/j.1469-0691.2006.01510.x. PubMed DOI

Villegas MV, Kattan JN, Correa A, et al. Dissemination of Acinetobacter baumannii clones with OXA-23 carbapenemase in Colombian hospitals. Antimicrob Agents Chemother. 2007;51:2001–2004. doi: 10.1128/AAC.00226-07. PubMed DOI PMC

Weldhagen GF, Prinsloo A. Molecular detection of GES-2 extended spectrum beta-lactamase producing Pseudomonas aeruginosa in Pretoria, South Africa. Int J Antimicrob Agents. 2004;24:35–38. doi: 10.1016/j.ijantimicag.2003.12.012. PubMed DOI

Wybo I, Blommaert L, De Beer T, et al. Outbreak of multidrug-resistant Acinetobacter baumannii in a Belgian university hospital after transfer of patients from Greece. J Hosp Infect. 2007;67:374–380. doi: 10.1016/j.jhin.2007.09.012. PubMed DOI

Zarrilli M, Giannouli M, Tomasone F, et al. Carbapenem resistance in Acinetobacter baumannii: the molecular epidemic features of an emerging problem in health care facilities. J Infect Dev Ctries. 2009;3:335–340. doi: 10.3855/jidc.240. PubMed DOI

Zong Z, Lü X, Valenzuela JK, et al. An outbreak of carbapenem-resistant Acinetobacter baumannii producing OXA-23 carbapenemase in western China. Int J Antimicrob Agents. 2008;31:50–54. doi: 10.1016/j.ijantimicag.2007.08.019. PubMed DOI